Guo C, Li J, Yang X, Xie W, et al. AEBP1 as a promising therapeutic target for skeletal muscle insulin resistance in type 2 diabetes mellitus: Convergent evidence from Mendelian randomization and functional validation. Metabolism 2025 Jul 4:156339. doi: 10.1016/j.metabol.2025.156339.
PMID: 40618921